Related Experiment Video
Updated: Mar 27, 2026
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Harnessing the power of oncolytic viruses for advancing cancer therapy
Yismaw Alemie Alemayehu1, Yared Abate Getahun2
1Department of Veterinary Science, College of Agriculture and Natural Resources, Debre Markos University, Burie P.O. Box 38, Ethiopia.
Abstract:
Oncolytic viruses are a novel and promising approach to cancer treatment. These viruses are either naturally occurring or genetically engineered to target and kill cancer cells while sparing healthy tissue. A growing body of research and clinical achievements is bolstering the use of oncolytic viruses. Adenoviruses, measles viruses, herpes simplex virus, and vaccinia viruses are some of the major oncolytic viruses used in cancer treatment. Oncolytic viruses function through different mechanisms: direct killing of tumor cells, immunological activation, and remodeling of the tumor microenvironment. Advancements in genetic engineering make oncolytic viruses a powerful anti-cancer tool by enhancing their tumor-specific targeting, reducing their pathogenic effects, and using viruses as vectors for expressing various therapeutic transgenes. Despite this promise, challenges such as tumor heterogeneity, physical barriers, immune clearance, and the immunosuppressive tumor environment can limit their effectiveness. This complexity necessitates combination therapies to improve OV efficacy and overcome tumor resistance. This article provides a comprehensive update on oncolytic viruses, genetic modification to enhance virotherapy, alongwith the hurdles and potential prospects for integrating this approach with existing cancer treatments.
Insights
Oncolytic viruses (OVs) offer a promising cancer therapy by targeting and destroying tumor cells. Genetic engineering enhances OV effectiveness, but combination therapies are crucial to overcome resistance.
Area of Science:
- Oncology
- Virology
- Biotechnology
Background:
- Oncolytic viruses (OVs) represent a novel therapeutic strategy in cancer treatment.
- These viruses selectively target and eliminate cancer cells while sparing normal tissues.
- Research and clinical successes are driving the increasing adoption of OVs.
Purpose of the Study:
- To provide a comprehensive update on the field of oncolytic viruses for cancer therapy.
- To discuss advancements in genetic engineering for enhanced virotherapy.
- To explore the challenges and future prospects of integrating OVs with current cancer treatments.
Main Methods:
- Review of current research on oncolytic viruses, including adenoviruses, measles viruses, herpes simplex virus, and vaccinia viruses.
- Analysis of mechanisms of action: direct tumor cell lysis, immune activation, and tumor microenvironment remodeling.
- Examination of genetic engineering strategies to improve tumor specificity and therapeutic payload delivery.
Main Results:
- OVs demonstrate multifaceted anti-cancer mechanisms, including direct killing and immune modulation.
- Genetic modifications enhance OV tumor targeting, reduce pathogenicity, and enable transgene expression.
- Challenges like tumor heterogeneity and immune suppression limit OV efficacy.
Conclusions:
- Oncolytic virotherapy holds significant promise as a cancer treatment modality.
- Genetic engineering is key to optimizing OV performance and overcoming limitations.
- Combination therapies are essential for maximizing OV efficacy and addressing tumor resistance.
Related Concept Videos
01:27Tumor Immunotherapy
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies